Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.64 |
| ▸ | HTR2A | P28223 | 4/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.46 |
| ▸ | HTR6 | P50406 | 3/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3060544 | 0.80 | TAAR1 (0.61) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL3064919 | 0.80 | TAAR1 (0.61) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL8851121 | 0.78 | TAAR1 (0.59) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL3052939 | 0.78 | TAAR1 (1.00) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL3158472 | 0.77 | SLC6A4 (0.50) | HTR2A | |
| SCHEMBL3052493 | 0.77 | TAAR1 (0.57) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| Hydrochloric Acid SCHEMBL9668097 | 0.76 | SLC6A4 (0.49) | HTR2A | |
| SCHEMBL3064865 | 0.76 | TAAR1 (0.61) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL29350459 | 0.75 | TSHR (0.50) | TAAR1 | |
| SCHEMBL150237 | 0.75 | TSHR (0.50) | TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2154123-B1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2013-10-23 | — | — | EP | disclosed |
| CN-101679171-B | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL CO | 2012-12-12 | — | — | CN | disclosed |
| US-7851659-B2 | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20100234645-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-09-16 | — | — | US | disclosed |
| CN-101679171-A | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL CO | 2010-03-24 | — | — | CN | disclosed |
| EP-2154123-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234645-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | NQO1, NQO2, NDUFC2 | TAAR1 1331/4885HTR2A 1458/4885HTR1A 2393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.